Inhibiting Signaling that Drives Growth of Rare Malformations
RARECast - En podkast av RARECast - Torsdager
Kategorier:
Thom Rossi, CEO of Venthera, discusses the company’s lead experimental therapy, its first-in-man-trial, and how it is leveraging the resources of BridgeBio.
